| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0845 | Azd4619 | Novel peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, inducing alanine aminotransferase-1 gene and protein expression in human, but not in rat hepatocytes |
|
| DCC0846 | Azd4996 | Novel potent and highly selective cathepsin K inhibitor for the treatment of osteoarthritis |
|
| DCC0847 | Azd5438-protac-8 | First-in-class selective, partial CDK2 degrader against hearing loss and cancer, protecting against cisplatin ototoxicity and kainic acid excitotoxicity |
|
| DCC0848 | Azd6370 | Glucokinase activator, decreasing fasting and postprandial glucose in type 2 diabetes mellitus patients |
|
| DCC0849 | Azd6564 | Novel Fibrinolysis Inhibitor, Acting via Interference of a Protein-Protein Interaction |
|
| DCC0850 | Azd6642 | Novel selective inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the treatment of inflammatory diseases |
|
| DCC0851 | Azd6703 | Novel, potent and selective inhibitor of p38α MAP kinase |
|
| DCC0852 | Azd7254 | Novel potent smoothened inhibitor, demonstrating in vivo activity in abrogating the Hh paracrine pathway as well as anti- tumor effects |
|
| DCC0853 | Azd9742 | Antimicrobials, active against methicillin resistant S. aureus (MRSA) |
|
| DCC0854 | Az-dyrk1b-33 | Potent and selective ATP-competitive Dyrk1B kinase inhibitor |
|
| DCC0855 | Azelastine | Potent, second-generation, selective histamine-H1-receptor antagonist and mast cell stabilizer |
|
| DCC0856 | Az-ghs-38 | Novel CNS penetrant potent inverse agonist of GHS-R1a (IC 50 (affinity) = 0.77 nM) |
|
| DCC0857 | Azide-a-dsbso Featured | Azide-A-DSBSO crosslinker is a mass spectrometry (MS)-cleavable, membrane-permeable, homobifunctional, azide-labeled, acid-cleavable cross-linked peptide. Azide-A-DSBSO crosslinker enables the study of protein-protein interactions via cross-linking mass spectrometry (XL-MS). |
|
| DCC0858 | Azido-tpp1 | Mitochondria-luciferin releasing agent, reacting with mitochondria-activatable luciferin (MAL-Probe), such as TPP-CL2, to release luciferin |
|
| DCC0859 | Azithromycin Monohydrate | Macrolide antibiotic, binding to the 50S subunit of the bacterial ribosome and thus inhibiting translation of mRNA |
|
| DCC0860 | Azocholine | Excellent photoswitchable agonist for neuronal α7 nAChRs |
|
| DCC0861 | Azogw1929 | Novel photoswitchable agonist for peroxisome proliferator-activated receptor γ (PPARγ) |
|
| DCC0862 | Azolig 9 | Novel photoswitchable ligand for the cannabinoid receptor 2 (CB2) |
|
| DCC0863 | Azorosi-4 | Novel photoswitchable agonist for peroxisome proliferator-activated receptor γ (PPARγ) |
|
| DCC0864 | Az-pfkfb3-26 | Potent and selective PFKFB3 inhibitor |
|
| DCC0865 | Azumamide E | Natural potent HDAC inhibitor |
|
| DCC0866 | Az-vem | Novel chimeric inhibitor of dimeric RAF, inhibiting B-Raf V600E mutan |
|
| DCC0867 | B07 Hydrochloride | Novel CCR5 antagonist-based HIV-1 entry inhibitor |
|
| DCC0868 | Ba-53038b | Novel HBV core protein allosteric modulator (CpAM), bing to the HAP pocket and modulating HBV capsid assembly in a distinct manner |
|
| DCC0869 | Baa485 | Novel activator of Pyrin inflammasome |
|
| DCC0870 | Bace1-in-cpd C | Novel potent nonbrain-penetrant BACE1 inhibitor |
|
| DCC0871 | Baclmk | Allosteric Inhibitor of the NS2B-NS3 Protease from Dengue Virus |
|
| DCC0872 | Bag-1 Inhibitor Thio-2 | Novel inhibitor of BAG-1-mediated protein interactions, targeting the RAF-MEK-ERK signaling pathway, transformed cells |
|
| DCC0873 | Bak2-66 | Selective Dopamine D3 Receptor Antagonist |
|
| DCC0874 | Bal101553 Dihydrochloride | Novel microtubule inhibitor as the prodrug of BAL27862, activating spindle assembly checkpoint, exerting antiproliferative effects and dose-dependent vascular disruption |
|
